Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 10 studies | 29% ± 10% | |
epithelial cell | 6 studies | 23% ± 7% | |
endothelial cell | 3 studies | 19% ± 2% | |
astrocyte | 3 studies | 25% ± 6% | |
dendritic cell | 3 studies | 20% ± 4% | |
abnormal cell | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 28% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 917.38 | 180 / 180 | 100% | 63.32 | 430 / 430 |
pancreas | 100% | 932.65 | 328 / 328 | 100% | 52.89 | 178 / 178 |
prostate | 100% | 1213.61 | 245 / 245 | 100% | 76.92 | 502 / 502 |
thymus | 100% | 959.88 | 653 / 653 | 100% | 49.66 | 605 / 605 |
uterus | 100% | 679.33 | 170 / 170 | 100% | 60.12 | 459 / 459 |
kidney | 100% | 962.78 | 89 / 89 | 100% | 38.05 | 900 / 901 |
brain | 100% | 854.93 | 2639 / 2642 | 100% | 46.76 | 705 / 705 |
bladder | 100% | 788.00 | 21 / 21 | 100% | 62.28 | 502 / 504 |
breast | 100% | 844.69 | 458 / 459 | 100% | 65.81 | 1114 / 1118 |
skin | 100% | 1181.92 | 1806 / 1809 | 100% | 60.38 | 470 / 472 |
lung | 99% | 819.16 | 574 / 578 | 100% | 56.51 | 1154 / 1155 |
esophagus | 99% | 847.30 | 1428 / 1445 | 100% | 37.35 | 183 / 183 |
intestine | 99% | 818.76 | 961 / 966 | 99% | 52.13 | 523 / 527 |
stomach | 99% | 695.33 | 357 / 359 | 99% | 43.58 | 283 / 286 |
liver | 100% | 734.96 | 226 / 226 | 98% | 38.04 | 398 / 406 |
adrenal gland | 100% | 1164.46 | 258 / 258 | 97% | 30.08 | 224 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 46.14 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 82.29 | 29 / 29 |
spleen | 100% | 1180.29 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 51.95 | 45 / 45 |
adipose | 99% | 684.42 | 1195 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1182.03 | 922 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 563.73 | 823 / 861 | 0% | 0 | 0 / 0 |
muscle | 95% | 482.99 | 763 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 457.70 | 1267 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2001242 | Biological process | regulation of intrinsic apoptotic signaling pathway |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_0062030 | Biological process | negative regulation of stress granule assembly |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0032515 | Biological process | negative regulation of phosphoprotein phosphatase activity |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0004864 | Molecular function | protein phosphatase inhibitor activity |
GO_0001691 | Molecular function | pseudophosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0019903 | Molecular function | protein phosphatase binding |
Gene name | STYXL1 |
Protein name | Serine/threonine/tyrosine-interacting-like protein 1 (Dual specificity phosphatase inhibitor MK-STYX) (Dual specificity protein phosphatase 24) (Inactive dual specificity protein phosphatase MK-STYX) (Map kinase phosphatase-like protein MK-STYX) Serine/threonine/tyrosine interacting like 1 |
Synonyms | MKSTYX DUSP24 |
Description | FUNCTION: Catalytically inactive phosphatase . By binding to G3BP1, inhibits the formation of G3BP1-induced stress granules . Does not act by protecting the dephosphorylation of G3BP1 at 'Ser-149' . Inhibits PTPMT1 phosphatase activity . By inhibiting PTPMT1, positively regulates intrinsic apoptosis . May play a role in the formation of neurites during neuronal development . . |
Accessions | A0A0C4DG63 Q9Y6J8 H0Y6C4 ENST00000360591.7 [Q9Y6J8-4] ENST00000438695.5 ENST00000248600.5 [Q9Y6J8-1] C9J4H0 ENST00000431581.5 [Q9Y6J8-1] H7C1Y2 ENST00000430497.5 ENST00000359697.8 [Q9Y6J8-1] ENST00000454618.5 ENST00000340062.9 [Q9Y6J8-4] ENST00000451157.1 |